Vale S.A. (0LBF)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 12.20 |
|---|---|
| 52-week range | 10.65 – 17.95 |
| Return, 1 month / 3 months | −12.9% / −16.0% |
| Return, 1 year / 3 years | +14.3% / +24.9% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 32.6% |
| Worst drawdown (1 year) | -30.1% |
| Average daily value traded | 0.55M USD |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vale is a Brazilian mining company based in Rio de Janeiro. It produces iron ore and iron ore pellets, which are supplied to steelmakers, and it also mines nickel, copper, manganese and potash. The company runs logistics operations that include railways and port terminals to move its output to customers around the world. Its products serve industrial buyers in the steel, metals and fertiliser industries, and it operates mines and processing facilities in Brazil and several other countries.
Vale S.A. trades under the code 0LBF on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vale S.A. (0LBF) trades on the London Exchange in UK. It last closed at USD 12.20 on 23 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 2,729 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.3% and over the last three months it fell 16.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 24 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.1% | ||
| From 52-week high | -31.7% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.0% | ||
| 6-month return | -28.2% | ||
| 12-month return, skipping the last month | 31.1% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.1% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.55M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.5% |
|---|---|
| 1 month | −12.9% |
| 3 months | −16.0% |
| 6 months | −28.2% |
| 1 year | +14.3% |
| 3 years | +24.9% |
| 5 years | +34.1% |
Signals
| 50-day / 200-day average | 14.13 / 15.07 |
|---|---|
| Golden / death cross (60 days) | Death, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | BRL 0.3267 |
| 12 Dec 2025 | BRL 0.6119 |
| 13 Aug 2025 | BRL 0.2854 |
| 10 Mar 2025 | BRL 0.3708 |
| 12 Dec 2024 | BRL 0.0689 |
| 5 Aug 2024 | BRL 0.3094 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.